Merck signposts a new strategy for patent owners in India
US pharmaceutical company Merck & Co – known as Merck Sharp & Dohme (MSD) outside of North America – has entered into an alliance with generic drug maker Cipla to co-market one of its antiretroviral treatments in India, Bloomberg reports. The…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.